HPC POS System, Corp. To Develop New Nutraceutical Cannabis Product Line
February 27 2014 - 7:30AM
Access Wire
Reno, NV / February 27, 2014 / ACCESSWIRE / HPC POS SYSTEM,
CORP. (PINKSHEETS: HPCS), a health company specializing in advances
in Supplements for Health, and Anti-Aging today announced that we
are entering into the medical Marijuana and Hemp space to cover all
sectors of the marketplace via a new holding company being created
called Cannabis Health Group. This will include the development of
edibles, ecommerce, cosmetics and software via their delivery
systems and the engagement of knowledgeable Technical Scientists in
this venue.
The goal of the Cannabis Health Group is to address a growing
demand in the nutraceutical market for naturally occurring
cannabinoids and, in particular, cannabidiol (CBD). CBD is related
to Δ9-tetrahydrocannabinol, (the psychoactive constituent of the
cannabis plant); however, it possesses no psychoactive properties.
“Although exciting research into the anti-inflammatory,
neuroprotective and immunosuppressive effects [1-3] of CBD
for such diseases as rheumatoid arthritis and Alzheimer’s is of
great interest to us, we are most excited about the anti-oxidant
properties of CBD when used as a nutritional supplement” said Fred
Schiemann, CEO of Cannabis Health Group. “A large body of research
currently being conducted into the potential health benefits of CBD
[4] particularly into its actions as an inhibitor of
cancer cell proliferation, metastasis, and tumor growth
[5-7] and Cannabis Health Group is planning to position
themselves to be a leading supplier of CBD-containing nutritional
supplements”
The Company expects to release its first product in the Spring
of 2014.
1. Malfait, A.M., et al., The nonpsychoactive cannabis
constituent cannabidiol is an oral anti-arthritic therapeutic in
murine collagen-induced arthritis. Proc Natl Acad Sci U S A, 2000.
97(17): p. 9561-6.
2. Mechoulam, R., L.A. Parker, and R. Gallily, Cannabidiol: an
overview of some pharmacological aspects. J Clin Pharmacol, 2002.
42(11 Suppl): p. 11S-19S.
3. Karl, T., et al., The therapeutic potential of the
endocannabinoid system for Alzheimer's disease. Expert Opin Ther
Targets, 2012. 16(4): p. 407-20.
4. Zuardi, A.W., Cannabidiol: from an inactive cannabinoid to a
drug with wide spectrum of action. Rev Bras Psiquiatr, 2008. 30(3):
p. 271-80.
5. McAllister, S.D., et al., Pathways mediating the effects of
cannabidiol on the reduction of breast cancer cell proliferation,
invasion, and metastasis. Breast Cancer Res Treat, 2011. 129(1): p.
37-47.
6. Marcu, J.P., et al., Cannabidiol enhances the inhibitory
effects of delta9-tetrahydrocannabinol on human glioblastoma cell
proliferation and survival. Mol Cancer Ther, 2010. 9(1): p.
180-9.
7. McAllister, S.D., et al., Cannabidiol as a novel inhibitor of
Id-1 gene expression in aggressive breast cancer cells. Mol Cancer
Ther, 2007. 6(11): p. 2921-7.
ABOUT WELLNESSBUILDER:
http://www.wellnessbuilder.com/
The Company specializes in advances in Supplements for Health,
and Anti-Aging with a special interest in Preventative Medicine.
The Company was formed to distribute nutraceutical formulas
developed over thirty years of research by world renowned team of
UCLA scientists. Wellnessbuilder scientists have created more than
a dozen fucoidan-based formulas which are intended to address the
needs of individuals suffering from DDS (Degenerative Disease
Syndrome), which includes such maladies as gastrointestinal
disorders, auto-immune diseases, asthma, Alzeimer's, dementia,
diabetes, arthritis, cancer, and heart disease.
Forward-Looking Statements:
This press release includes forward-looking statements
concerning the future performance of our business, its operations
and its financial performance and condition, and also includes
selected operating results presented without the context of
accompanying financial results. These forward-looking statements
include, among others, statements with respect to our objectives
and strategies to achieve those objectives, as well as statements
with respect to our beliefs, plans, expectations, anticipations,
estimates or intentions. These forward-looking statements are based
on our current expectations. We caution that all forward-looking
information is inherently uncertain and actual results may differ
materially from the assumptions, estimates or expectations
reflected or contained in the forward-looking information, and that
actual future performance will be affected by a number of factors,
including economic conditions, technological change, regulatory
change and competitive factors, many of which are beyond our
control. Therefore, future events and results may vary
significantly from what we currently foresee. We are under no
obligation (and we expressly disclaim any such obligation) to
update or alter the forward-looking statements whether as a result
of new information, future events or otherwise.
Contact for this Press Release:
Fred Schiemann, Marketing/Public Relations
Email: fschiemann@wellnessbuilder.com; fschiemann@yahoo.com
Source: HPC POS SYSTEM, CORP.
Interactive Health Network (CE) (USOTC:IGRW)
Historical Stock Chart
From Jul 2024 to Aug 2024
Interactive Health Network (CE) (USOTC:IGRW)
Historical Stock Chart
From Aug 2023 to Aug 2024